Noronex Limited
  • Home
  • Corporate
    • Board / Management
    • Corporate Directory
    • Corporate Governance
  • Investors
    • ASX Announcements
    • Investor Presentations
    • Shareholder Services
    • Right to Receive Documents
    • Target Market Determination
  • Contact
  • Search
  • Menu Menu

Pre-Quotation Disclosure

November 14, 2017/in ASX Announcements/by webandprint
Tags: LRM
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
https://noronexlimited.com.au/wp-content/uploads/2020/11/Noronex-Limited-web.png 0 0 webandprint https://noronexlimited.com.au/wp-content/uploads/2020/11/Noronex-Limited-web.png webandprint2017-11-14 07:49:002017-11-14 07:49:00Pre-Quotation Disclosure
You might also like
Appendix 3E
Appendix 1A and Information Form and Checklist
Addendum Notice of Meeting/Updated Proxy Form
Quarterly Activities Report and Appendix 5B – Mar 2019
Appendix 3E
Appendix 3E
Change of Director’s Interest Notice x 2
Notification of Release of Restricted Shares from Escrow

Noronex Limited

ACN 609 594 005

Suite 1, 295 Rokeby Road
Subiaco, WA 6008 Australia

Ph: +61 (8) 6555 2950

E: info@noronex.com.au

Latest News


Join Our Mailing List

© Copyright - Noronex Limited - Website by Web and Print Design
  • Home
  • Corporate
  • Investors
  • Contact
  • Privacy Policy
  • Terms of Use
ASX NoticeDistribution Schedule
Scroll to top